Search
for
Sort by
Research 661–690 of 1000+
- Epidermal growth factor, innovation and safety
- Rationale and Design of a Novel, Phase 3, External and Synthetic Placebo-Controlled Clinical Trial of Ritlecitinib 50 mg and 100 mg for Alopecia Areata
- Poster Abstracts
- The Impact of Covid-19 Pandemic on the Clinical Course of Pediatric Skin Disorders: A Cross-Sectional Study
- Scalpel, Toxin, and Performance Pressure: Metabolic, Psychiatric, and Psychosocial Aspects of Aesthetic Medicine in Competitive and Physique Athletes
- Emerging smart microneedle technologies in psoriasis: convergence of nanocarriers, machine learning, and personalized delivery
- Treating Psoriasis: What Is New About Fumaric Acid Esters?
- Signal transducer and activator of transcription 5B deficiency due to a novel missense mutation in the coiled-coil domain
- 153 Effectiveness of OR-101, a next generation highly selective JAK3 inhibitor, in a humanized murine model of alopecia areata
- ROS-responsive hydrogel-delivered miR-665 targets STAT3 to alleviate inflammation and promote hair follicle regeneration in alopecia areata
- In Silico Structure-Based Drug Design Approach To Evaluate Quercetin And Kaempferol As Dual Inhibitors Of Jak3 Kinase And 5-Alpha Reductase Type II with ADMET Profiling
- In Silico Structure-Based Drug Design Approach To Evaluate Quercetin And Kaempferol As Dual Inhibitors Of Jak3 Kinase And 5-Alpha Reductase Type II with ADMET Profiling
- Deciphering the molecular drivers for cashmere/pashmina fiber production in goats: a comprehensive review
- Tofacitinib in the Recalcitrant Cases of Alopecia Areata: A Pilot Study
- 0480 Upadacitinib monotherapy for treatment of pyoderma gangrenosum: A case series
- A Comprehensive Review on Alopecia: Mechanisms, Classification, and Therapeutic Strategies
- A Comprehensive Review on Alopecia: Mechanisms, Classification, and Therapeutic Strategies
- Tru9I Variant as a Novel Genetic Marker for Vitamin D Deficiency in Alopecia Areata
- LB1048 Effectiveness of OR-101 in a murine model of atopic dermatitis
- 6ER-014 Evaluation of baricitinib in paediatric patients with alopecia areata
- Transcriptome analysis of frontal fibrosis alopecia revealed involvement of immune cells and ferroptosis
- Hair follicle targeting via gelatin coated transferosomes loaded with tofacitinib citrate for enhanced treatment of alopecia areata: Clinical evaluation of alopecia areata patients
- Case Report: Successful Treatment of Alopecia Universalis With Tofacitinib and Increased Cytokine Levels: Normal Therapeutic Reaction or Danger Signal?
- A phase 2a trial of brepocitinib for cicatricial alopecia
- A Patient Preference-Weighted Quantitative Benefit-Risk Analysis of Ritlecitinib for Alopecia Areata to Inform Medical Decision Making
- Application of Baricitinib in Dermatology
- Defining a Therapeutic Window of Opportunity in Alopecia Areata: Predictors of Early Response to Baricitinib
- Off-Label Uses of Abrocitinib: Review of Emerging Therapeutic Applications beyond Atopic Dermatitis
- Evaluating the Causal Relationship Between Human Blood Metabolites and the Susceptibility to Alopecia Areata
- Topical Delivery of Tofacitinib in Dermatology: The Promise of a Novel Therapeutic Class Using Biodegradable Dendritic Polyglycerol Sulfates